Can zapping cancer spots with Super-Precise radiation delay the disease?
NCT ID NCT03808337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a very focused, high-dose radiation treatment (SBRT) to all visible cancer spots can delay the cancer from getting worse in people with breast or lung cancer that has spread to 1-5 places. About 145 participants will either receive standard care alone or standard care plus SBRT to each metastasis. The goal is to see if the radiation helps keep the disease under control longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stereotactic body radiotherapy (SBRT) – a precise, high-dose radiation treatment
- What this could lead to
- If it works, this could show that targeting all visible cancer spots with radiation helps keep the disease from getting worse for longer, potentially improving control of metastatic cancer.
- What could go wrong
- This is a mid-stage trial with only 145 participants, so results may not apply to everyone. SBRT can cause side effects like fatigue or damage to nearby organs, and it may not improve survival or prevent new metastases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baptist Alliance - McI
RECRUITINGMiami, Florida, 33143, United States
-
Hartford Healthcare
RECRUITINGHartford, Connecticut, 06102, United States
-
Lehigh Valley Health Network
RECRUITINGAllentown, Pennsylvania, 18103, United States
-
Memorial Sloan Kettering Basking Ridge
RECRUITINGBasking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen
RECRUITINGMontvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Commack
RECRUITINGCommack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
RECRUITINGMiddletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau
RECRUITINGUniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
RECRUITINGHarrison, New York, 10604, United States
-
Natera, Inc. (Data and Specimen Analysis Only)
NOT_YET_RECRUITINGSan Carlos, California, 94070, United States
-
WCHN Norwalk Hospital - Data Collection
RECRUITINGNorwalk, Connecticut, 06850, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?